bromocriptine has been researched along with Hypertrophy, Left Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Aguilar, C; Belio-Caro, F; Mejía-Rodríguez, O; Paniagua-Sierra, JR; Vargas-Espinosa, JM; Vega-Gómez, HE | 1 |
| Ansari, A; Balligand, JL; Bonda, T; Desjardins, F; Doerries, C; Drexler, H; Forster, O; Heusch, G; Hilfiker, A; Hilfiker-Kleiner, D; Kaminski, K; Klein, G; Landmesser, U; Luchtefeld, M; Nguyen, NQ; Podewski, E; Poli, V; Quint, A; Schaefer, A; Schneider, MD; Schulz, R; Sliwa, K; Struman, I; Zschemisch, NH | 1 |
2 trial(s) available for bromocriptine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Bromocriptine induces regression of left ventricular hypertrophy in peritoneal dialysis patients.
Topics: Adult; Blood Pressure; Bromocriptine; Dopamine Agonists; Echocardiography; Female; Heart Rate; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prolactin | 2005 |
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
Topics: Animals; Bromocriptine; Cardiomyopathies; Cathepsin D; Disease Models, Animal; Female; Heart Transplantation; Humans; Hypertrophy, Left Ventricular; Lactation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Neovascularization, Pathologic; Oxidative Stress; Peptide Fragments; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Prolactin; Puerperal Disorders; STAT3 Transcription Factor | 2007 |